Skip to main content

Peer Review reports

From: Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)

Original Submission
26 Oct 2021 Submitted Original manuscript
3 Dec 2021 Reviewed Reviewer Report
3 Dec 2021 Reviewed Reviewer Report
4 Jan 2022 Author responded Author comments - Yongin Cho
Resubmission - Version 2
4 Jan 2022 Submitted Manuscript version 2
7 Jan 2022 Reviewed Reviewer Report
29 Jan 2022 Reviewed Reviewer Report
7 Feb 2022 Author responded Author comments - Yongin Cho
Resubmission - Version 3
7 Feb 2022 Submitted Manuscript version 3
Publishing
8 Feb 2022 Editorially accepted
21 Mar 2022 Article published 10.1186/s12916-022-02288-2

You can find further information about peer review here.

Back to article page